InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Yeramian Patrick D, Directeur Médical. Officer active across 1 company, notably Amylyx Pharmaceuticals, Inc.. In total, 8 reports have been logged. Split: 0 buy · 4 sells. Total volume traded: €1.7m. Activity tracked since 6 January 2022. The latest transaction was filed on 9 January 2024 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Yeramian Patrick D
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
2,812 shares@ US$16.32812.5% of flowCommon StockSEC:0000950170-24-003974:0
2,201 shares@ US$0.370.0% of flowCommon StockSEC:0000950170-23-022775:0
44,861 shares@ US$0.370.9% of flowCommon StockSEC:0000899243-23-011461:0
2,789 shares@ US$0.330.1% of flowCommon StockSEC:0000899243-23-009600:0
52,211 shares@ US$31.848592.4% of flowCommon StockSEC:0000899243-23-009178:0
1,405 shares@ US$36.07892.8% of flowCommon StockSEC:0000899243-23-001526:0
629 shares@ US$36.78881.3% of flowCommon StockSEC:0000899243-23-001526:1
28,333 shares0Common StockSEC:0000899243-22-001522:0
8 of 8 declarations
About Yeramian Patrick D
Yeramian Patrick D is Directeur Médical and Chief Medical Officer at Amylyx Pharmaceuticals, Inc. The declarant has 8 filings in total, and among the sampled recent filings from 2022-01-10 to 2024-01-11, the modal transaction nature is Cession, with sum_sell_eur of 1683278 and sum_buy_eur of 0.
